Atlas Trials

Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma

Clinical trial NCT02689167 · UNKNOWN

Trial details

NCT number
NCT02689167
Sponsor
Centre Hospitalier Universitaire de Besancon
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney NeoplasmsMetastatic Renal Cell Cancer
Start date
2016-02-19
Primary completion
2024-02-01
Enrollment
226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.